Endocyte Inc. buy melinda
Start price
07.10.17
/
50%
€5.06
Target price
27.12.17
€5.41
Performance (%)
-21.03%
End price
27.12.17
€4.00
Summary
This prediction ended on 27.12.17 with a price of €4.00. The prediction for Endocyte Inc. disappointed with a performance of -21.03%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endocyte Inc. | - | - | - | - |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% | 44.608% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% | 70.742% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% | 48.205% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% | 54.254% |
Comments by melinda for this prediction
In the thread Endocyte Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
(Vom Mitglied beendet)